Skip to Content
AP National Business

Biogen cuts the price tag on its Alzheimer’s drug in half

yonkershonda.com / CC BY-SA 2.0
By
Published 7:30 AM

By TOM MURPHY
AP Health Writer

Biogen is slashing the price of its Alzheimer’s treatment months after the drug debuted to widespread criticism for an initial cost that can reach $56,000 annually. The drugmaker said Monday that starting in January it will cut the wholesale acquisition cost of the drug by about 50%. That means the annual cost for a person of average weight will amount to $28,200. Biogen CEO Michel Vounatsos said in a statement that too many patients were not being offered the drug due to “financial considerations,” and their disease had progressed beyond the point where Aduhelm could help. 

Article Topic Follows: AP National Business

Jump to comments ↓

Associated Press

BE PART OF THE CONVERSATION

KRDO NewsChannel 13 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.